Revenue, Gross Profit, Gross Profit Margin and Operating Income (Loss) by Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 27, 2024	Sep. 29, 2023	Sep. 27, 2024	Sep. 29, 2023
Segment Reporting Information [Line Items]
Revenue	$ 244,405	$ 221,503	$ 711,185	$ 670,093
Gross Profit	$ 109,215	$ 101,591	$ 313,320	$ 303,342
Gross profit margin percentage	44.70%	45.90%	44.10%	45.30%
Operating Income (Loss)	$ 32,555	$ 30,309	$ 83,877	$ 88,819
Operating Segments | Precision Medicine and Manufacturing
Segment Reporting Information [Line Items]
Revenue	60,595	71,277	189,781	215,138
Gross Profit	$ 27,048	$ 36,208	$ 89,412	$ 107,054
Gross profit margin percentage	44.60%	50.80%	47.10%	49.80%
Operating Income (Loss)	$ 11,879	$ 18,508	$ 40,367	$ 54,803
Operating Segments | Medical Solutions
Segment Reporting Information [Line Items]
Revenue	103,783	83,378	310,760	244,340
Gross Profit	$ 42,373	$ 34,027	$ 122,128	$ 100,170
Gross profit margin percentage	40.80%	40.80%	39.30%	41.00%
Operating Income (Loss)	$ 12,421	$ 11,050	$ 36,686	$ 30,974
Operating Segments | Robotics and Automation
Segment Reporting Information [Line Items]
Revenue	80,027	66,848	210,644	210,615
Gross Profit	$ 40,569	$ 32,652	$ 104,506	$ 100,376
Gross profit margin percentage	50.70%	48.80%	49.60%	47.70%
Operating Income (Loss)	$ 22,086	$ 12,208	$ 48,950	$ 39,456
Unallocated Corporate and Shared Services
Segment Reporting Information [Line Items]
Gross Profit	(775)	(1,296)	(2,726)	(4,258)
Operating Income (Loss)	$ (13,831)	$ (11,457)	$ (42,126)	$ (36,414)